Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Gene Therapy
CRISPR
Biotechnology
About
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Details
Status
Active
Stage
Early
Team Size
2
Regions
United States of America, America / Canada, Remote, Partly Remote